Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2.
Vitamin A metabolites such as all-trans-retinoic acid (all-trans-RA) affect several steps of metabolic processes in vertebrates. In the last few years, several studies have shown the effect of RA on bone formation and metabolism. However, mechanisms of its action still remain unclear, especially with respect to the regulation of bone cells. Therefore, this study was carried out to clarify how RA regulates the activity of osteoclasts. Using a pit assay involving unfractionated bone cells, including osteoclasts obtained from rabbits, we found that RA stimulated an increase in the bone-resorbing activity in a dose- and time-dependent manner. Furthermore, this effect occurred more rapidly than that of treatments with 1 alpha,25-dihydroxyvitamin D3. However, this effect of RA may be partly related to cross-talk between osteoclasts and other types of cells. Therefore we studied the effect of RA on isolated osteoclasts. We found that all-trans-RA regulates the gene expression of cathepsin K/OC-2, a dominant cysteine proteinase, at the transcriptional level in mature osteoclasts isolated from rabbits. Moreover, retinoic acid-receptor alpha mRNA and retinoid X-receptor beta mRNA were expressed in these mature osteoclasts. Our results indicate that osteoclasts are target cells for RA and that RA might regulate a part of bone formation and metabolism through osteoclasts.
Saneshige
S
S
Fourth Department of Internal Medicine, Saitama Medical School, Japan.
Mano
H
H
Tezuka
K
K
Kakudo
S
S
Mori
Y
Y
Honda
Y
Y
Itabashi
A
A
Yamada
T
T
Miyata
K
K
Hakeda
Y
Y
D000818:Animals; D001862:Bone Resorption; D056657:Cathepsin K; D002403:Cathepsins / Q000235:genetics*; D002478:Cells, Cultured; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D010010:Osteoclasts / Q000187:drug effects*; D011817:Rabbits; D018168:Receptors, Retinoic Acid / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects; D014212:Tretinoin / Q000494:pharmacology*
D018168:Receptors, Retinoic Acid; D014212:Tretinoin; D002403:Cathepsins; D056657:Cathepsin K